2023 Q3 Form 10-K Financial Statement

#000137647423000411 Filed on August 15, 2023

View on sec.gov

Income Statement

Concept 2023 Q3 2023 Q2 2023
Revenue $9.924M $10.72M $40.20M
YoY Change 9.16% 11.0% 30.24%
Cost Of Revenue $5.539M $6.153M $24.13M
YoY Change -2.92% -0.48% 8.52%
Gross Profit $4.385M $4.567M $16.07M
YoY Change 29.54% 31.44% 86.22%
Gross Profit Margin 44.18% 42.6% 39.97%
Selling, General & Admin $2.336M $2.282M $8.160M
YoY Change 27.58% 33.52% 32.58%
% of Gross Profit 53.28% 49.97% 50.79%
Research & Development $129.1K $215.5K $1.097M
YoY Change -65.61% -78.45% -9.58%
% of Gross Profit 2.94% 4.72% 6.83%
Depreciation & Amortization $455.5K $468.5K $1.472M
YoY Change 43.33% 27.7% 9.28%
% of Gross Profit 10.39% 10.26% 9.17%
Operating Expenses $2.465M $2.497M $9.257M
YoY Change 11.72% 46.12% 25.64%
Operating Profit $1.920M $2.069M $6.809M
YoY Change 62.9% 17.22% 175.36%
Interest Expense $698.9K $698.9K
YoY Change 15293.39% 15293.39%
% of Operating Profit 33.77% 10.26%
Other Income/Expense, Net $361.3K -$435.6K $696.3K
YoY Change 803.34% -13927.3% 732.43%
Pretax Income $2.281M $2.333M $7.505M
YoY Change 87.21% 31.56% 193.59%
Income Tax $433.0K $266.0K $1.218M
% Of Pretax Income 18.98% 11.4% 16.23%
Net Earnings $1.848M $2.067M $6.287M
YoY Change 84.35% 36.4% 180.76%
Net Earnings / Revenue 18.62% 19.28% 15.64%
Basic Earnings Per Share $0.52 $1.79
Diluted Earnings Per Share $0.52 $0.56 $1.77
COMMON SHARES
Basic Shares Outstanding 3.521M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2023 Q3 2023 Q2 2023
SHORT-TERM ASSETS
Cash & Short-Term Investments $30.70M $28.09M $28.09M
YoY Change 34.74% 18.95% 18.95%
Cash & Equivalents $2.889M $3.575M $3.575M
Short-Term Investments $27.81M $24.51M $24.51M
Other Short-Term Assets $439.0K $228.9K $668.6K
YoY Change 4.89% -67.5% -5.09%
Inventory $6.830M $5.941M $10.07M
Prepaid Expenses $439.6K
Receivables $5.400M $5.554M $5.554M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $46.76M $44.38M $44.38M
YoY Change 23.81% 16.85% 16.85%
LONG-TERM ASSETS
Property, Plant & Equipment $11.69M $11.72M $11.72M
YoY Change 12.76% 18.95% 18.95%
Goodwill
YoY Change
Intangibles $0.00
YoY Change
Long-Term Investments
YoY Change
Other Assets $1.810M $1.782M $1.782M
YoY Change 41.17% 28.44% 28.44%
Total Long-Term Assets $13.51M $13.50M $13.50M
YoY Change 15.91% 20.12% 20.12%
TOTAL ASSETS
Total Short-Term Assets $46.76M $44.38M $44.38M
Total Long-Term Assets $13.51M $13.50M $13.50M
Total Assets $60.27M $57.88M $57.88M
YoY Change 21.95% 17.6% 17.6%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.051M $1.718M $1.718M
YoY Change -27.43% 20.38% 20.38%
Accrued Expenses $2.463M $4.078M $3.710M
YoY Change 22.49% 79.54%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $8.327M $7.788M $7.788M
YoY Change 62.3% 30.59% 30.59%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $8.327M $7.788M $7.788M
Total Long-Term Liabilities $0.00 $0.00 $0.00
Total Liabilities $8.330M $7.788M $7.788M
YoY Change 62.35% 30.59% 30.59%
SHAREHOLDERS EQUITY
Retained Earnings $43.98M $42.13M
YoY Change 19.36% 17.54%
Common Stock $11.07M $102.1K
YoY Change 6.79% -99.01%
Preferred Stock
YoY Change
Treasury Stock (at cost) $3.101M $3.085M
YoY Change 6.36% 5.82%
Treasury Stock Shares
Shareholders Equity $51.94M $50.09M $50.09M
YoY Change
Total Liabilities & Shareholders Equity $60.27M $57.88M $57.88M
YoY Change 21.95% 17.6% 17.6%

Cashflow Statement

Concept 2023 Q3 2023 Q2 2023
OPERATING ACTIVITIES
Net Income $1.848M $2.067M $6.287M
YoY Change 84.35% 36.4% 180.76%
Depreciation, Depletion And Amortization $455.5K $468.5K $1.472M
YoY Change 43.33% 27.7% 9.28%
Cash From Operating Activities $3.038M $6.366M $7.707M
YoY Change -9936.56% 117.98% 132.94%
INVESTING ACTIVITIES
Capital Expenditures $427.7K $977.0K $3.359M
YoY Change -48.69% -245.9% 141.42%
Acquisitions
YoY Change
Other Investing Activities $1.128K -$5.239M $4.761K
YoY Change -1.05% -49480.3% 112.54%
Cash From Investing Activities -$3.727M -$6.216M -$26.78M
YoY Change 346.53% 843.28% 1827.65%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net -$133.0K
YoY Change -918.5%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities $2.883K 41.48K $133.0K
YoY Change -91.83% 960.87% 718.25%
NET CHANGE
Cash From Operating Activities $3.038M 6.366M $7.707M
Cash From Investing Activities -$3.727M -6.216M -$26.78M
Cash From Financing Activities $2.883K 41.48K $133.0K
Net Change In Cash -$685.8K 191.4K -$18.94M
YoY Change -20.77% -91.55% -1086.97%
FREE CASH FLOW
Cash From Operating Activities $3.038M $6.366M $7.707M
Capital Expenditures $427.7K $977.0K $3.359M
Free Cash Flow $2.610M $5.389M $4.347M
YoY Change -402.02% 50.11% 126.78%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023 dei Document Type
DocumentType
10-K
CY2023 dei Document Annual Report
DocumentAnnualReport
true
CY2023 dei Document Period End Date
DocumentPeriodEndDate
2023-05-31
CY2023 dei Document Transition Report
DocumentTransitionReport
false
CY2023 dei Entity File Number
EntityFileNumber
000-3498
CY2023 dei Entity Registrant Name
EntityRegistrantName
TAYLOR DEVICES INC
CY2023 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NY
CY2023 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
16-0797789
CY2023 dei Entity Address Address Line1
EntityAddressAddressLine1
90 Taylor Drive
CY2023 dei Entity Address City Or Town
EntityAddressCityOrTown
North Tonawanda
CY2023 dei Entity Address State Or Province
EntityAddressStateOrProvince
NY
CY2023 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
14120
CY2023 dei Entity Address Address Description
EntityAddressAddressDescription
Address of principal executive offices
CY2023 dei Phone Fax Number Description
PhoneFaxNumberDescription
Registrant's telephone number, including area code
CY2023 dei City Area Code
CityAreaCode
716
CY2023 dei Local Phone Number
LocalPhoneNumber
694-0800
CY2023 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2023 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2023 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2023 dei Entity Small Business
EntitySmallBusiness
true
CY2023 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2023 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
false
CY2023 dei Document Fin Stmt Error Correction Flag
DocumentFinStmtErrorCorrectionFlag
false
CY2023 dei Entity Shell Company
EntityShellCompany
false
CY2022Q4 dei Entity Public Float
EntityPublicFloat
46934000 usd
CY2023Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
3521377 shares
CY2023 dei Auditor Name
AuditorName
Lumsden & McCormick, LLP
CY2023 dei Auditor Firm
AuditorFirmId
130
CY2023 dei Auditor Location
AuditorLocation
Buffalo, New York
CY2023Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
3575219 usd
CY2022Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
22517038 usd
CY2023Q2 us-gaap Short Term Investments
ShortTermInvestments
24514757 usd
CY2022Q2 us-gaap Short Term Investments
ShortTermInvestments
1097450 usd
CY2022Q2 us-gaap Accounts And Other Receivables Net Current
AccountsAndOtherReceivablesNetCurrent
4466686 usd
CY2022Q2 us-gaap Inventory Parts And Components Net Of Reserves
InventoryPartsAndComponentsNetOfReserves
5854935 usd
CY2023Q2 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
439607 usd
CY2022Q2 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
468489 usd
CY2023Q2 us-gaap Other Assets Current
OtherAssetsCurrent
228947 usd
CY2022Q2 us-gaap Other Assets Current
OtherAssetsCurrent
235947 usd
CY2022Q2 us-gaap Costs In Excess Of Billings On Uncompleted Contracts Or Programs
CostsInExcessOfBillingsOnUncompletedContractsOrPrograms
3336474 usd
CY2023Q2 us-gaap Assets Current
AssetsCurrent
44377520 usd
CY2022Q2 us-gaap Assets Current
AssetsCurrent
37977019 usd
CY2022Q2 us-gaap Other Inventory Noncurrent
OtherInventoryNoncurrent
1107309 usd
CY2022Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
9854759 usd
CY2023Q2 us-gaap Other Assets Miscellaneous Noncurrent
OtherAssetsMiscellaneousNoncurrent
210120 usd
CY2022Q2 us-gaap Other Assets Miscellaneous Noncurrent
OtherAssetsMiscellaneousNoncurrent
205359 usd
CY2022Q2 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
74615 usd
CY2023Q2 us-gaap Assets
Assets
57881179 usd
CY2022Q2 us-gaap Assets
Assets
49219061 usd
CY2023Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
1717657 usd
CY2022Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
1426830 usd
CY2022Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
3414314 usd
CY2022Q2 us-gaap Billings In Excess Of Cost Current
BillingsInExcessOfCostCurrent
1122763 usd
CY2023Q2 us-gaap Liabilities Current
LiabilitiesCurrent
7788449 usd
CY2022Q2 us-gaap Liabilities Current
LiabilitiesCurrent
5963907 usd
CY2023Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.025
CY2022Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.025
CY2023Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
8000000 shares
CY2022Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
8000000 shares
CY2023Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
4088193 shares
CY2023Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
4088193 shares
CY2022Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
4056771 shares
CY2022Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
4056771 shares
CY2023Q2 us-gaap Common Stock Value
CommonStockValue
102127 usd
CY2022Q2 us-gaap Common Stock Value
CommonStockValue
101342 usd
CY2023Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
10947089 usd
CY2022Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
10227916 usd
CY2023Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
42128256 usd
CY2022Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
35840898 usd
CY2023Q2 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
567751 shares
CY2022Q2 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
558834 shares
CY2023Q2 us-gaap Treasury Stock Value
TreasuryStockValue
3084742 usd
CY2022Q2 us-gaap Treasury Stock Value
TreasuryStockValue
2915002 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
50092730 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
43255154 usd
CY2023Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
57881179 usd
CY2022Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
49219061 usd
CY2022 us-gaap Revenues
Revenues
30866582 usd
CY2023 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
24133312 usd
CY2022 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
21239886 usd
CY2023 us-gaap Gross Profit
GrossProfit
16066042 usd
CY2022 us-gaap Gross Profit
GrossProfit
9626696 usd
CY2023 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1096807 usd
CY2022 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
999184 usd
CY2023 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
8160169 usd
CY2022 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
6154735 usd
CY2023 us-gaap Operating Income Loss
OperatingIncomeLoss
6809066 usd
CY2022 us-gaap Operating Income Loss
OperatingIncomeLoss
2472777 usd
CY2023 us-gaap Investment Income Interest
InvestmentIncomeInterest
698864 usd
CY2022 us-gaap Investment Income Interest
InvestmentIncomeInterest
4543 usd
CY2023 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-2572 usd
CY2022 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
79103 usd
CY2023 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
696292 usd
CY2022 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
83646 usd
CY2023 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
7505358 usd
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
2556423 usd
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
317000 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
6287358 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
2239423 usd
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.64
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.64
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
50092730 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
43255154 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
6287358 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
2239423 usd
CY2023 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1472455 usd
CY2022 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1347442 usd
CY2023 us-gaap Stock Option Plan Expense
StockOptionPlanExpense
417253 usd
CY2022 us-gaap Stock Option Plan Expense
StockOptionPlanExpense
201278 usd
CY2023 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-23360 usd
CY2022 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 usd
CY2023 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
-20015 usd
CY2022 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
1530 usd
CY2023 us-gaap Gain Loss On Condemnation
GainLossOnCondemnation
-295014 usd
CY2022 us-gaap Gain Loss On Condemnation
GainLossOnCondemnation
0 usd
CY2023 us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
-494000 usd
CY2022 us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
115500 usd
CY2023 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
1110178 usd
CY2022 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
346122 usd
CY2023 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
277214 usd
CY2022 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-486191 usd
CY2023 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-28882 usd
CY2022 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-54258 usd
CY2023 us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
-7000 usd
CY2022 us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
-218831 usd
CY2023 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-787708 usd
CY2022 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-1836870 usd
CY2023 us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
290827 usd
CY2022 us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
-360495 usd
CY2023 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
664008 usd
CY2022 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
1429841 usd
CY2023 us-gaap Increase Decrease In Billing In Excess Of Cost Of Earnings
IncreaseDecreaseInBillingInExcessOfCostOfEarnings
869707 usd
CY2022 us-gaap Increase Decrease In Billing In Excess Of Cost Of Earnings
IncreaseDecreaseInBillingInExcessOfCostOfEarnings
-239222 usd
CY2023 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
7706779 usd
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
3308525 usd
CY2023 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
3359495 usd
CY2022 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1391577 usd
CY2023 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
0 usd
CY2022 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
7500 usd
CY2023 us-gaap Payments To Acquire Other Investments
PaymentsToAcquireOtherInvestments
23417307 usd
CY2022 us-gaap Payments To Acquire Other Investments
PaymentsToAcquireOtherInvestments
438 usd
CY2023 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
4761 usd
CY2022 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
4821 usd
CY2023 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-26781563 usd
CY2022 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1389336 usd
CY2023 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
302705 usd
CY2022 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
16245 usd
CY2023 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
169740 usd
CY2022 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
0 usd
CY2023 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
132965 usd
CY2022 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
16245 usd
CY2023 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-18941819 usd
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
1935434 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
22517038 usd
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
20581604 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
3575219 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
22517038 usd
CY2023 us-gaap Nature Of Operations
NatureOfOperations
<p style="font:10pt Times New Roman;margin:0;color:#000080;text-align:justify"><b>Nature of Operations:</b></p> <p style="font:10pt Times New Roman;margin:0;color:#000000;text-align:justify"> </p> <p style="font:10pt Times New Roman;margin:0;color:#000000;text-align:justify">Taylor Devices, Inc. (the Company) manufactures and sells a single group of very similar products that have many different applications for customers.  These similar products are included in one of eight categories; namely, Seismic Dampers, Fluidicshoks®, Crane and Industrial Buffers, Self-Adjusting Shock Absorbers, Liquid Die Springs, Vibration Dampers, Machined Springs and Custom Actuators for use in various types of machinery, equipment and structures, primarily to customers which are located throughout the United States and several foreign countries.  The products are manufactured at the Company's sole operating facility in the United States where all of the Company's long-lived assets reside. Management does not track or otherwise account for sales broken down by these categories.</p> <p style="font:10pt Times New Roman;margin:0;color:#000000;text-align:justify"> </p> <p style="font:10pt Times New Roman;margin:0;color:#000000;text-align:justify">81% of the Company's 2023 revenue was generated from sales to customers in the United States and 11% was from sales to customers in Asia.  Remaining sales were to customers in other countries in North America, Europe, Australia, and South America.</p> <p style="font:10pt Times New Roman;margin:0;color:#000000;text-align:justify"> </p> <p style="font:10pt Times New Roman;margin:0;color:#000000;text-align:justify">76% of the Company's 2022 revenue was generated from sales to customers in the United States and 14% was from sales to customers in Asia.  Remaining sales were to customers in other countries in North America, Europe, Australia, and South America.</p>
CY2023 us-gaap Use Of Estimates
UseOfEstimates
<p style="font:10pt Times New Roman;margin:0;color:#000080;text-align:justify"><b>Use of Estimates:</b></p> <p style="font:10pt Times New Roman;margin:0;color:#000000;text-align:justify"> </p> <p style="font:10pt Times New Roman;margin:0;color:#000000;text-align:justify">The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes.  Actual results could differ from those estimates.</p>
CY2023 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
1710000 usd
CY2022 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
200100 usd
CY2023 us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<p style="font:10pt Times New Roman;margin:0;color:#000080;text-align:justify"><b>Reclassifications:</b></p> <p style="font:10pt Times New Roman;margin:0;color:#000000;text-align:justify"> </p> <p style="font:10pt Times New Roman;margin:0;color:#000000;text-align:justify">The 2022 financial statements have been reclassified to conform with the presentation adopted for 2023.</p>
CY2023Q2 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
5582970 usd
CY2022Q2 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
4482792 usd
CY2023Q2 us-gaap Allowance For Doubtful Accounts Premiums And Other Receivables
AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables
29466 usd
CY2022Q2 us-gaap Allowance For Doubtful Accounts Premiums And Other Receivables
AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables
16106 usd
CY2023Q2 us-gaap Accounts And Other Receivables Net Current
AccountsAndOtherReceivablesNetCurrent
5553504 usd
CY2022Q2 us-gaap Accounts And Other Receivables Net Current
AccountsAndOtherReceivablesNetCurrent
4466686 usd
CY2023Q2 us-gaap Inventory Gross
InventoryGross
6009304 usd
CY2022Q2 us-gaap Inventory Gross
InventoryGross
5954935 usd
CY2023Q2 us-gaap Inventory Adjustments
InventoryAdjustments
68000 usd
CY2022Q2 us-gaap Inventory Adjustments
InventoryAdjustments
100000 usd
CY2023Q2 us-gaap Inventory Net
InventoryNet
5941304 usd
CY2022Q2 us-gaap Inventory Net
InventoryNet
5854935 usd
CY2023 fil Costs Incurred On Uncompleted Contracts
CostsIncurredOnUncompletedContracts
5349111 usd
CY2022 fil Costs Incurred On Uncompleted Contracts
CostsIncurredOnUncompletedContracts
4268608 usd
CY2023 fil Costs Incurred On Uncompleted Contracts Estimated Earnings
CostsIncurredOnUncompletedContractsEstimatedEarnings
4850889 usd
CY2022 fil Costs Incurred On Uncompleted Contracts Estimated Earnings
CostsIncurredOnUncompletedContractsEstimatedEarnings
3211392 usd
CY2023 fil Costs Incurred On Uncompleted Contracts Gross
CostsIncurredOnUncompletedContractsGross
10200000 usd
CY2022 fil Costs Incurred On Uncompleted Contracts Gross
CostsIncurredOnUncompletedContractsGross
7480000 usd
CY2023 fil Costs Incurred On Uncompleted Contracts Billings To Date
CostsIncurredOnUncompletedContractsBillingsToDate
8068288 usd
CY2022 fil Costs Incurred On Uncompleted Contracts Billings To Date
CostsIncurredOnUncompletedContractsBillingsToDate
5266289 usd
CY2023 fil Costs Incurred On Uncompleted Contracts Net
CostsIncurredOnUncompletedContractsNet
2131712 usd
CY2022 fil Costs Incurred On Uncompleted Contracts Net
CostsIncurredOnUncompletedContractsNet
2213711 usd
CY2023 fil Costs And Estimated Earnings In Excess Of Billings
CostsAndEstimatedEarningsInExcessOfBillings
4124182 usd
CY2022 fil Costs And Estimated Earnings In Excess Of Billings
CostsAndEstimatedEarningsInExcessOfBillings
3336474 usd
CY2023 fil Billings In Excess Of Costs And Estimated Earnings
BillingsInExcessOfCostsAndEstimatedEarnings
-1992470 usd
CY2022 fil Billings In Excess Of Costs And Estimated Earnings
BillingsInExcessOfCostsAndEstimatedEarnings
-1122763 usd
CY2023 fil Costs Incurred On Uncompleted Contracts Net
CostsIncurredOnUncompletedContractsNet
2131712 usd
CY2022 fil Costs Incurred On Uncompleted Contracts Net
CostsIncurredOnUncompletedContractsNet
2213711 usd
CY2023Q2 fil Number Of Projects In Progress
NumberOfProjectsInProgress
22 pure
CY2022Q2 fil Number Of Projects In Progress
NumberOfProjectsInProgress
19 pure
CY2023Q2 fil Aggregate Percent Complete
AggregatePercentComplete
0.33 pure
CY2022Q2 fil Aggregate Percent Complete
AggregatePercentComplete
0.47 pure
CY2023Q2 fil Aggregate Amount Remaining
AggregateAmountRemaining
18061484 usd
CY2022Q2 fil Aggregate Amount Remaining
AggregateAmountRemaining
7627234 usd
CY2023Q2 fil Percentage Of Total Value Invoiced To Customer
PercentageOfTotalValueInvoicedToCustomer
0.29 pure
CY2022Q2 fil Percentage Of Total Value Invoiced To Customer
PercentageOfTotalValueInvoicedToCustomer
0.35 pure
CY2023 fil Revenues Recognized For Amounts Included In Billings In Excess Of Costs And Estimated Earnings
RevenuesRecognizedForAmountsIncludedInBillingsInExcessOfCostsAndEstimatedEarnings
1123000 usd
CY2022 fil Revenues Recognized For Amounts Included In Billings In Excess Of Costs And Estimated Earnings
RevenuesRecognizedForAmountsIncludedInBillingsInExcessOfCostsAndEstimatedEarnings
1362000 usd
CY2023 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
2000 usd
CY2022 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
1400 usd
CY2023 us-gaap Current Federal State And Local Tax Expense Benefit
CurrentFederalStateAndLocalTaxExpenseBenefit
1712000 usd
CY2022 us-gaap Current Federal State And Local Tax Expense Benefit
CurrentFederalStateAndLocalTaxExpenseBenefit
201500 usd
CY2023 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-494000 usd
CY2022 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
115500 usd
CY2023 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
0 usd
CY2023Q2 fil Maintenance And Other Inventory Gross
MaintenanceAndOtherInventoryGross
2236106 usd
CY2022Q2 fil Maintenance And Other Inventory Gross
MaintenanceAndOtherInventoryGross
2334889 usd
CY2023Q2 fil Maintenance And Other Inventory Allowance For Obsolescence
MaintenanceAndOtherInventoryAllowanceForObsolescence
1232966 usd
CY2022Q2 fil Maintenance And Other Inventory Allowance For Obsolescence
MaintenanceAndOtherInventoryAllowanceForObsolescence
1227580 usd
CY2023Q2 fil Maintenance And Other Inventory Net
MaintenanceAndOtherInventoryNet
1003140 usd
CY2022Q2 fil Maintenance And Other Inventory Net
MaintenanceAndOtherInventoryNet
1107309 usd
CY2023 fil Inventory Disposed Of
InventoryDisposedOf
322000 usd
CY2022 fil Inventory Disposed Of
InventoryDisposedOf
772000 usd
CY2023 fil Provision For Potential Inventory Obsolescence
ProvisionForPotentialInventoryObsolescence
295000 usd
CY2022 fil Provision For Potential Inventory Obsolescence
ProvisionForPotentialInventoryObsolescence
0 usd
CY2023Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
28857274 usd
CY2022Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
26094875 usd
CY2023Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
17135490 usd
CY2022Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
16240116 usd
CY2023Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
11721784 usd
CY2022Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
9854759 usd
CY2023 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1472455 usd
CY2022 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1347442 usd
CY2023Q2 us-gaap Other Commitment
OtherCommitment
107000 usd
CY2022 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
0 usd
CY2023Q2 us-gaap Line Of Credit
LineOfCredit
10000000 usd
CY2023 us-gaap Line Of Credit Facility Average Outstanding Amount
LineOfCreditFacilityAverageOutstandingAmount
0 usd
CY2022 us-gaap Line Of Credit Facility Average Outstanding Amount
LineOfCreditFacilityAverageOutstandingAmount
0 usd
CY2023Q2 fil Outstanding Checks
OutstandingChecks
13873 usd
CY2022Q2 fil Outstanding Checks
OutstandingChecks
193478 usd
CY2023Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
4078322 usd
CY2022Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
3414314 usd
CY2023 us-gaap Revenues
Revenues
40199354 usd
CY2022 us-gaap Revenues
Revenues
30866582 usd
CY2023 us-gaap Deferred Federal State And Local Tax Expense Benefit
DeferredFederalStateAndLocalTaxExpenseBenefit
-494000 usd
CY2022 us-gaap Deferred Federal State And Local Tax Expense Benefit
DeferredFederalStateAndLocalTaxExpenseBenefit
115500 usd
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1218000 usd
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
317000 usd
CY2023 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
1576100 usd
CY2022 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
536800 usd
CY2023 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
-1600 usd
CY2022 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
1100 usd
CY2023 us-gaap Income Tax Reconciliation Tax Credits Research
IncomeTaxReconciliationTaxCreditsResearch
283600 usd
CY2022 us-gaap Income Tax Reconciliation Tax Credits Research
IncomeTaxReconciliationTaxCreditsResearch
275400 usd
CY2023 us-gaap Income Tax Reconciliation Tax Credits Foreign
IncomeTaxReconciliationTaxCreditsForeign
66900 usd
CY2022 us-gaap Income Tax Reconciliation Tax Credits Foreign
IncomeTaxReconciliationTaxCreditsForeign
12200 usd
CY2023 us-gaap Income Tax Reconciliation Other Reconciling Items
IncomeTaxReconciliationOtherReconcilingItems
900 usd
CY2022 us-gaap Income Tax Reconciliation Other Reconciling Items
IncomeTaxReconciliationOtherReconcilingItems
3100 usd
CY2023 fil Other Adjustments
OtherAdjustments
-6900 usd
CY2022 fil Other Adjustments
OtherAdjustments
63600 usd
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1218000 usd
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
317000 usd
CY2023 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.162 pure
CY2022 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.124 pure
CY2023Q2 fil Allowance For Doubtful Receivables
AllowanceForDoubtfulReceivables
6200 usd
CY2022Q2 fil Allowance For Doubtful Receivables
AllowanceForDoubtfulReceivables
3400 usd
CY2023Q2 fil Tax Inventory Adjustment
TaxInventoryAdjustment
84300 usd
CY2022Q2 fil Tax Inventory Adjustment
TaxInventoryAdjustment
92200 usd
CY2023Q2 fil Allowance For Obsolete Inventory
AllowanceForObsoleteInventory
273200 usd
CY2022Q2 fil Allowance For Obsolete Inventory
AllowanceForObsoleteInventory
278800 usd
CY2023Q2 fil Accrued Vacation
AccruedVacation
136600 usd
CY2022Q2 fil Accrued Vacation
AccruedVacation
84300 usd
CY2023Q2 fil Accrued Commissions
AccruedCommissions
9800 usd
CY2022Q2 fil Accrued Commissions
AccruedCommissions
7000 usd
CY2023Q2 fil Warranty Reserve
WarrantyReserve
62700 usd
CY2022Q2 fil Warranty Reserve
WarrantyReserve
48800 usd
CY2023Q2 fil Rd Tax Credit
RDTaxCredit
0 usd
CY2022Q2 fil Rd Tax Credit
RDTaxCredit
84000 usd
CY2023Q2 fil Rd Capitalization
RDCapitalization
678500 usd
CY2022Q2 fil Rd Capitalization
RDCapitalization
0 usd
CY2023Q2 fil Stock Options Issued For Services
StockOptionsIssuedForServices
331300 usd
CY2022Q2 fil Stock Options Issued For Services
StockOptionsIssuedForServices
277600 usd
CY2023Q2 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
1582600 usd
CY2022Q2 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
876100 usd
CY2023Q2 fil Excess Tax Depreciation
ExcessTaxDepreciation
1013985 usd
CY2022Q2 fil Excess Tax Depreciation
ExcessTaxDepreciation
801485 usd
CY2023Q2 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
568615 usd
CY2022Q2 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
74615 usd
CY2023Q2 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
1582600 usd
CY2023 fil Average Common Shares Outstanding
AverageCommonSharesOutstanding
3506474 shares
CY2022 fil Average Common Shares Outstanding
AverageCommonSharesOutstanding
3497345 shares
CY2023 fil Common Shares Issuable Under Stock Option Plans
CommonSharesIssuableUnderStockOptionPlans
45020 shares
CY2022 fil Common Shares Issuable Under Stock Option Plans
CommonSharesIssuableUnderStockOptionPlans
2208 shares
CY2023 fil Average Common Shares Outstanding Assuming Dilution
AverageCommonSharesOutstandingAssumingDilution
3551494 shares
CY2022 fil Average Common Shares Outstanding Assuming Dilution
AverageCommonSharesOutstandingAssumingDilution
3499553 shares
CY2023 fil Common Shares Issued To Employees
CommonSharesIssuedToEmployees
922 shares
CY2022 fil Common Shares Issued To Employees
CommonSharesIssuedToEmployees
1496 shares
CY2023Q2 fil Shares Reserved For Further Issue
SharesReservedForFurtherIssue
216365 shares
CY2023 us-gaap Loss Contingency Lawsuit Filing Date
LossContingencyLawsuitFilingDate
September 23, 2021
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0245 pure
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0259 pure
CY2023 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P4Y2M12D
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P4Y
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.33 pure
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.31 pure
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0 pure
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0 pure
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
267750 shares
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
11.60
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
271426 usd
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
66750 shares
CY2022 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
10.69
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
51500 shares
CY2022 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
0
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
283000 shares
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
11.43
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
28248 usd
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
85000 shares
CY2023 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
15.75
CY2023 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
30500 shares
CY2023 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
9.57
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
4500 shares
CY2023 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
0
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
333000 shares
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
12.70
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
2016961 usd
CY2023 fil Preferred Stock Authorized But Unissued
PreferredStockAuthorizedButUnissued
2000000 shares
CY2023Q2 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
567751 shares
CY2022Q2 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
558834 shares
CY2023 us-gaap Pension And Other Postretirement Benefit Expense
PensionAndOtherPostretirementBenefitExpense
371881 usd
CY2022 us-gaap Pension And Other Postretirement Benefit Expense
PensionAndOtherPostretirementBenefitExpense
313269 usd
CY2023 us-gaap Interest Paid
InterestPaid
0 usd
CY2022 us-gaap Interest Paid
InterestPaid
0 usd
CY2023 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
1705000 usd
CY2022 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
CY2023 us-gaap Loss Contingency Parties Jointly And Severally Liable In Litigation
LossContingencyPartiesJointlyAndSeverallyLiableInLitigation
Taylor Devices Inc. (the “Company”) has been named as a Third-Party Defendant
CY2023 us-gaap Loss Contingency Name Of Plaintiff
LossContingencyNameOfPlaintiff
Board of Managers of the 432 Park Condominium, et al
CY2023 us-gaap Loss Contingency Name Of Defendant
LossContingencyNameOfDefendant
56th and Park (NY) Owner LLC, et al
CY2023 us-gaap Loss Contingency Allegations
LossContingencyAllegations
The Owner alleges “over 1500 identified construction and design defects to the common elements of” residential and commercial units at the Building, based upon a report generated by a consultant (SBI Consultants Inc.) retained by the Owner
CY2023 us-gaap Loss Contingency Managements Assessment And Process
LossContingencyManagementsAssessmentAndProcess
Management of the Company vigorously disputes the allegations in the Third-Party Complaint.
CY2023 us-gaap Loss Contingency Inestimable Loss
LossContingencyInestimableLoss
it is not practical to quantify likely damages to the Company in the event of an unfavorable outcome on liability

Files In Submission

Name View Source Status
0001376474-23-000411-index-headers.html Edgar Link pending
0001376474-23-000411-index.html Edgar Link pending
0001376474-23-000411.txt Edgar Link pending
0001376474-23-000411-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R79.htm Edgar Link pending
R8.htm Edgar Link pending
R80.htm Edgar Link pending
R81.htm Edgar Link pending
R82.htm Edgar Link pending
R83.htm Edgar Link pending
R84.htm Edgar Link pending
R85.htm Edgar Link pending
R86.htm Edgar Link pending
R87.htm Edgar Link pending
R88.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
tayd-20230531.htm Edgar Link pending
tayd-20230531.xsd Edgar Link pending
td_ex31z1.htm Edgar Link pending
td_ex31z2.htm Edgar Link pending
td_ex32z1.htm Edgar Link pending
td_ex32z2.htm Edgar Link pending
tayd-20230531_cal.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
tayd-20230531_def.xml Edgar Link unprocessable
tayd-20230531_lab.xml Edgar Link unprocessable
tayd-20230531_pre.xml Edgar Link unprocessable
tayd-20230531_htm.xml Edgar Link completed